BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6453301)

  • 1. Topography of neurofibrillary tangles and granulovacuoles in hippocampi of patients with Down's syndrome: quantitative comparison with normal ageing and Alzheimer's disease.
    Ball MJ; Nuttall K
    Neuropathol Appl Neurobiol; 1981; 7(1):13-20. PubMed ID: 6453301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topographic distribution of neurofibrillary tangles and granulovacuolar degeneration in hippocampal cortex of aging and demented patients. A quantitative study.
    Ball MJ
    Acta Neuropathol; 1978 May; 42(2):73-80. PubMed ID: 654888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topography of Pick inclusion bodies in hippocampi of demented patients. A quantitative study.
    Ball MJ
    J Neuropathol Exp Neurol; 1979 Nov; 38(6):614-20. PubMed ID: 230324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.
    Hof PR; Bouras C; Perl DP; Sparks DL; Mehta N; Morrison JH
    Arch Neurol; 1995 Apr; 52(4):379-91. PubMed ID: 7710374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some morphometric observations on the cerebral cortex and hippocampus in presenile Alzheimer's disease, senile dementia of Alzheimer type and Down's syndrome in middle age.
    Mann DM; Yates PO; Marcyniuk B
    J Neurol Sci; 1985 Jul; 69(3):139-59. PubMed ID: 3162000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. A quantitative study.
    Ball MJ
    Acta Neuropathol; 1977 Feb; 37(2):111-8. PubMed ID: 848276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype.
    Hyman BT; West HL; Rebeck GW; Lai F; Mann DM
    Arch Neurol; 1995 Apr; 52(4):373-8. PubMed ID: 7710373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibrillary tangles, granulovacuolar degeneration, and neuron loss in Down Syndrome: quantitative comparison with Alzheimer dementia.
    Ball MJ; Nuttall K
    Ann Neurol; 1980 May; 7(5):462-5. PubMed ID: 6446875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topographic relationship between neurofibrillary change and acetylcholinesterase rich neurons in the upper brain stem of patients with senile dementia of the Alzheimer's type and Down's syndrome.
    Shortridge BA; Vogel FS; Burger PC
    Clin Neuropathol; 1985; 4(6):227-37. PubMed ID: 2934202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative investigation of neurofibrillary damage in the temporal lobe in Alzheimer's disease, Down's syndrome and dementia pugilistica.
    McKenzie JE; Roberts GW; Royston MC
    Neurodegeneration; 1996 Sep; 5(3):259-64. PubMed ID: 8910904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease and Down's syndrome.
    Mann DM
    Histopathology; 1988 Aug; 13(2):125-37. PubMed ID: 2971602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of neurones from cortical and subcortical areas in Down's syndrome patients at middle age. Quantitative comparisons with younger Down's patients and patients with Alzheimer's disease.
    Mann DM; Yates PO; Marcyniuk B; Ravindra CR
    J Neurol Sci; 1987 Aug; 80(1):79-89. PubMed ID: 2956368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of the pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome.
    Burger PC; Vogel FS
    Am J Pathol; 1973 Nov; 73(2):457-76. PubMed ID: 4271339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small cerebral hemispheres in adults with Down's syndrome: contributions of developmental arrest and lesions of Alzheimer's disease.
    de la Monte SM; Hedley-Whyte ET
    J Neuropathol Exp Neurol; 1990 Sep; 49(5):509-20. PubMed ID: 2148772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The amygdala in Down's syndrome and familial Alzheimer's disease: four clinicopathological case reports.
    Murphy GM; Ellis WG
    Biol Psychiatry; 1991 Jul; 30(1):92-106. PubMed ID: 1832566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cerebral degeneration in Down's syndrome].
    Hirabayashi K; Ikeda K; Shimokawa K; Orthner H
    Folia Psychiatr Neurol Jpn; 1979; 33(1):81-96. PubMed ID: 156670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes.
    Mann DM; Yates PO; Marcyniuk B
    Neuropathol Appl Neurobiol; 1984; 10(3):185-207. PubMed ID: 6234474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer-type dementia and Down's syndrome: solubility of neurofibrillary tangles is related to duration of dementia.
    Hussey S; Yates CM; Christie JE; Elton RA; Gordon A
    J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):823-4. PubMed ID: 2956365
    [No Abstract]   [Full Text] [Related]  

  • 19. The topography of plaques and tangles in Down's syndrome patients of different ages.
    Mann DM; Yates PO; Marcyniuk B; Ravindra CR
    Neuropathol Appl Neurobiol; 1986; 12(5):447-57. PubMed ID: 2946973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The substantia nigra and ventral tegmental area in Alzheimer's disease and Down's syndrome.
    Gibb WR; Mountjoy CQ; Mann DM; Lees AJ
    J Neurol Neurosurg Psychiatry; 1989 Feb; 52(2):193-200. PubMed ID: 2539435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.